The apology came after the Supreme Court’s observation during a hearing related to Patanjali Ayurved Ltd.’s misleading advertisements case on April 23, where the court suggested that the IMA should address internal issues.
NEW DELHI: On 4th July: Dr. R V Asokan, the Chief of the Indian Medical Association (IMA), issued a public apology on Thursday for his remarks made in an interview regarding a comment by the Supreme Court during a case involving the IMA. He expressed regret over his statement, emphasizing that he never intended to diminish the dignity of the court.
READ ALSO: Supreme Court Criticizes IMA for Prescribing Expensive, Unnecessary Medicines
The apology came after the Supreme Court’s observation during a hearing related to Patanjali Ayurved Ltd.’s misleading advertisements case on April 23, where the court suggested that the IMA should address internal issues.
“The statement issued by the doctors’ association conveyed that Dr. R V Asokan, the National President of IMA, has apologized for his remarks to the press concerning a Supreme Court comment during a case in which the IMA was involved.”
READ ALSO: “Be Prepared for More Serious Consequences”: SC Warned IMA President in Patanjali Case
Dr. Asokan also submitted an affidavit to the court offering an unconditional apology for his comments. The IMA has filed a writ petition against misleading advertisements and malicious campaigns targeting modern medicine professionals.
“IMA has filed a writ petition with the Supreme Court addressing misleading advertisements and malicious campaigns targeting modern medicine professionals. In light of statements I made during an interview, I have expressed regret to the Supreme Court and submitted an affidavit tendering my unconditional apology,”
Dr. Asokan stated. He emphasized,
“I had no intention of diminishing the majesty or dignity of the Supreme Court,”
reaffirming his apology.
“The bench highlighted numerous complaints regarding alleged unethical practices by some Association members, including the misuse of patient trust by prescribing excessively costly medications and recommending unnecessary investigations for extraneous reasons as part of treatment,”
the statement noted.
Dr. Asokan highlighted that promoting ethical practices within the association is a priority, noting recent efforts such as engaging with patient groups and releasing a joint declaration in Bangalore to address patient concerns.
FOLLOW US FOR MORE LEGAL UPDATES ON YOUTUBE
